drug interaction
Showing 1 - 25 of >10,000
Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole
Completed
- Drug-drug Interaction Study
- SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Nov 20, 2023
Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)
Completed
- Diabetes in Adults
- Hydrochlorothiazide、Henagliflozin Proline
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 12, 2023
Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)
Active, not recruiting
- Healthy
- Drug-Drug Interaction
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Sep 30, 2023
Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)
Recruiting
- Drug Drug Interaction
- Digoxin
- +4 more
-
Guangzhou, ChinaThe First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023
Healthy Volunteer Study Trial in Québec (Cohort 1 BEM + Ruzasvir, Cohort 2 Ruzasvir + BEM)
Recruiting
- Healthy Volunteer Study
- Cohort 1 BEM + Ruzasvir
- Cohort 2 Ruzasvir + BEM
-
Québec, Montreal, Quebec, CanadaAtea Study Site
Feb 9, 2023
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Drug Drug Interaction, Warfarin, Midazolam Trial in Guangzhou (ZSP1273)
Active, not recruiting
- Drug Drug Interaction
- +2 more
-
Guangzhou, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Jul 4, 2023
Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)
Recruiting
- Drug Interaction
- ZX-7101A
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 21, 2023
Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)
Enrolling by invitation
- Drug Interactions
- Methotrexate Sodium
- Rifampicin
-
Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 25, 2023
Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)
Completed
- Healthy Participant
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 11, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023
Healthy Female Volunteers Trial (BMS-986196, Loestrin)
Not yet recruiting
- Healthy Female Volunteers
- (no location specified)
May 26, 2023
Drug Interaction Trial in San Antonio (Ecopipam, Cohort 1 Probe Substrate Cocktail, Cohort 2 Probe Substrate)
Completed
- Drug Interaction
- Ecopipam
- +3 more
-
San Antonio, TexasICON Early Phase Services
Dec 9, 2022
Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)
Completed
- Multiple Sclerosis
- Tolebrutinib
- +2 more
-
Saint Paul, MinnesotaPrism Research-Site Number:8400001
Sep 26, 2023
Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)
Not yet recruiting
- Healthy
-
Dallas, TexasLabcorp Clinical Research LP
Jun 8, 2023
Drug Interaction, Analgesics, Opioid Trial in Richmond (Lemborexant, Placebo)
Recruiting
- Drug Interaction
- Analgesics, Opioid
- Lemborexant
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University
Nov 28, 2022
Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,
Active, not recruiting
- Healthy Volunteers
- Cohort 1: SIM0417/ritonavir and itraconazole
- +2 more
-
Jinan, Shandong, ChinaShandong First Medical University
Jan 13, 2023